2023
DOI: 10.1101/2023.02.17.528570
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Disease-specific loss of microbial cross-feeding interactions in the human gut

Abstract: Many gut microorganisms critical to human health rely on nutrients produced by each other for survival; however, these cross-feeding interactions are still challenging to quantify and remain poorly characterized. Here we introduce a Metabolite Exchange Score (MES) to quantify those interactions. Using metagenome-wide metabolic models from over 1600 individuals, the MES allowed us to identify and rank metabolic interactions that were significantly affected by a loss of cross-feeding partners in 10 out of 11 dis… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
9
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(17 citation statements)
references
References 59 publications
(64 reference statements)
0
9
0
Order By: Relevance
“…As our ability to de novo assemble metagenomic datasets gets better, and as new biosynthetic classes are characterized, the comprehensiveness of our approach will increase. Second, an enriched small molecule BGC does not necessitate a causative role in disease, but could also indicate a selection process as a consequence of the disease, where the produced molecule provides a survival or competitive advantage to the producer (Marcelino et al, 2023; Watson et al, 2023). For example, it is often suggested that the expansion of facultative anaerobes in the CD microbiome is a consequence of disease-associated inflammation and oxidative stress (Morgan et al, 2012).…”
Section: Discussionmentioning
confidence: 99%
“…As our ability to de novo assemble metagenomic datasets gets better, and as new biosynthetic classes are characterized, the comprehensiveness of our approach will increase. Second, an enriched small molecule BGC does not necessitate a causative role in disease, but could also indicate a selection process as a consequence of the disease, where the produced molecule provides a survival or competitive advantage to the producer (Marcelino et al, 2023; Watson et al, 2023). For example, it is often suggested that the expansion of facultative anaerobes in the CD microbiome is a consequence of disease-associated inflammation and oxidative stress (Morgan et al, 2012).…”
Section: Discussionmentioning
confidence: 99%
“…Instead, they might simply be the only ones capable of surviving in a poorly diverse gut. The study also adds key evidence to the growing awareness of the relationships between microbial cross-feeding and microbiome composition, paving the way to test interesting questions in future research ( Wang et al, 2019 ; Marcelino et al, 2023 ; Gralka et al, 2020 ; Watson et al, 2023 ). For example, what are the roles of bacteria with high metabolic independence in re-establishing a healthy gut microbiome after disruption?…”
mentioning
confidence: 82%
“…Conversely, the cysK gene, involved in metabolizing H2S in the biosynthesis of cysteine, increased throughout LPD (Fig. 4k) [39,40]. Similarly, there was an increase in the bsh gene that metabolizes taurine and aids in the deconjugation of tauro-conjugated bile acids excreted to the gut from the biliary tree (Fig.…”
Section: Changes In Functional Metagenomic Features Associated With L...mentioning
confidence: 97%
“…Interestingly, LPD led to a reduced amount of cysJ, a critical enzyme for producing hydrogen sulfide (H2S) from sulfite, and a reduced amount of dycD, key for H2S production from cysteine (Fig. 4k) [39,40]. Conversely, the cysK gene, involved in metabolizing H2S in the biosynthesis of cysteine, increased throughout LPD (Fig.…”
Section: Changes In Functional Metagenomic Features Associated With L...mentioning
confidence: 98%
See 1 more Smart Citation